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Abstract: 
Background: 
 Fetal Alcohol Syndrome (FAS), located on the severe end of a spectrum of disorders 
known as Fetal Alcohol Spectrum Disorders (FASDs), is one of the most detrimental, and 
publicized, teratogenic outcome of alcohol consumption during pregnancy within the United 
States. During pregnancy, alcohol that is consumed by the mother passes through the placenta 
and transfers to the baby via the umbilical cord. The same prenatal transference of alcohol that 
leads to FAS and FASDs might also be contributing to an increased likelihood of hypertension in 
youth. Additionally, factors such as stress influenced by familial instability, an increased 
likelihood of developing congenital and conotruncal heart defects, and a reduction in nephron 
count might be leading to an increased likelihood of hypertension in FAS-affected youth. The 
purpose of this study is to examine the relationship between prenatal exposure to alcohol, 
manifested through FAS, and hypertension in children, adolescents, and young adults. 
Methods: 
 A case-control study design was incorporated to analyze the association between FAS 
status and hypertensions status; cases (n=165) were collected from a FAS clinical database in 
Atlanta, Georgia. Controls (n=177) were taken from the National Health and Nutrition 
Examination Survey (NHANES). 
 Chi-square analyses were used to examine the extent to which FAS status, sex, 
race/ethnicity, medication use, and obesity status each relate to hypertension status. A logistic 
regression was performed analyzing the relationship between FAS status (y/n: independent) and 
hypertension status (y/n: dependent) whilst controlling for sex, race/ethnicity, medication use, 
and obesity status. 
Results: 
 The univariate relationships between FAS status and hypertension status (OR=4.491, 
p<.001) as well as medication use and hypertension status (OR= 2.951, p=.002) proved to be 
statistically significant (p<.05). Through the regression, FAS status significantly predicted 
hypertension status (β = 1.646, OR = 5.184, p< .001) after accounting for sex, race/ethnicity, 
medication use, and obesity status. Those with a race/ethnicity categorized as either Non-
Hispanic African American (β =1.259, OR = 3.523, p = .049) or Hispanic (β = 1.192, OR = 
3.294, p = .061) were significantly more likely to have hypertensions than those categorized as 
non-Hispanic Caucasian. 
Conclusion: 
 The major findings of this study suggest a significant relationship between FAS and 
hypertension in youth. Race/ethnicity also proved important in predicting hypertensive blood 
pressure readings independent of FAS diagnosis. The most obvious biological mechanism 
catalyzing the relationship between FAS and hypertension is prenatal alcohol exposure. Because 
prenatal alcohol exposure is the primary definitional and diagnostic factor of FAS, associative 
connectivity may exist independently between prenatal alcohol exposure and blood pressure at 
various levels of severity along an alcohol exposure dose-response spectrum. Further research is 
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needed to isolate and measure the effect that prenatal alcohol exposure has on blood pressure 
independently of FAS as well as to assess the extent to which the risk for hypertension in 
alcohol-affected individuals increases with age and through the life course. 
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Background:  
FAS and FASDs  
Fetal Alcohol Syndrome (FAS), located on the severe end of a spectrum of disorders 
known as Fetal Alcohol Spectrum Disorders (FASDs), was first identified in 1973 and remains 
one of the most detrimental, publicized, and teratogenic outcomes of alcohol consumption during 
pregnancy within the United States.1,2 FAS has been estimated to impact anywhere between 0.5 
to 2 live births per 1000 whilst FASDs are believed to affect 3 times as many people as FAS.3 
The diagnostic criteria for FAS include diminished anthropometric growth (typically below the 
10th percentile), facial abnormalities (smooth philtrum and reduced palpebral fissures), and 
impaired cognitive development.4,5,6 Those affected by FAS experience an increased risk for a 
range of health burdens including brain dysfunction, mental impairment, physical 
dysmorphia/abnormalities, psychological disorders, learning disabilities, spontaneous abortion, 
and death.7 There is no cure for FAS, but the causes are 100% preventable.8,66 
Treatment for FAS is often focused on reducing disability through mental health and 
medical services.9 Many of the neurodevelopmental conditions that result from FAS impair 
academic and adaptive functioning throughout childhood and into adulthood. Research shows 
that early diagnosis is key in ensuring optimal developmental outcomes for children with 
FAS.10,11 But health burdens relating to FAS reach far beyond impaired physical and cognitive 
capacity. Some research has shown that having FAS increases the likelihood of incarceration into 
adulthood; although these findings remain inconsistent within the literature.12,75,76 The actual 
prevalence of FASDs in the correctional system is estimated to be about 9.1 per 1,000 inmates.74 
Children with FAS, similar to children with other disabilities, have also shown to be much more 
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likely to face caregiver, familial, and residential instability.13,14 Instabilities faced by these 
children places them at a greater risk for stress; a primary determinant of hypertension.15,16 
Hypertension 
It is estimated that almost a third of all non-institutionalized adults are classified as 
hypertensive within the United States.17,18,19 For youth in particular, the rates of high blood 
pressure, or hypertension, have shown to be significantly increasing.20,21 This marked increase 
has been correlated with factors such as an uptick in the overall prevalence of obesity in children 
and the overconsumption of sodium (Na) in the U.S.22 High blood pressure has a particularly 
high health burden because its prognosis is multifaceted. Hypertension elevates the risk for 
serious conditions such as renal failure, heart attack, stroke, and brain damage whilst often 
producing no obvious signs or symptoms in the patient.23,24 National medical costs directly 
related to hypertension are projected to increase to an annual total of $200.3 billion dollars by 
2030.25 Much of this heightened national cost is attributable to the increased likelihood of 
progressive morbidity and mortality faced by hypertensive patients.26 Hypertension is also listed 
as one of the leading risk factors for cardiovascular disease; a disease that accounts for around 
25% of all deaths in the U.S.27 
Though it can be a devastating burden to an individual’s health, hypertensionis a 
condition that is both preventable and reversible.28 One of the most effective methods of 
preventing hypertension and prehypertension is the continuous monitoring of blood pressure of 
at-risk individuals.29 Normal blood pressure readings tend to be those that are less than 120/80 
mmHg, but this varies by age.30 Another effective method of maintaining healthy blood pressure 
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levels in youth relates to the reduction of alcohol consumption; the overconsumption of alcohol 
often leads to the increasingly-prevalent condition ofalcohol-induced hypertension.31 
Alcohol Exposure and Hypertension 
Alcohol abuse continues to be one of the most frequent preventable contributors to high 
blood pressure and prehypertension in the U.S.32,33 There is a dose-response relationship between 
the levels of alcohol consumed and blood pressure; greater consumption of alcohol results in an 
increased likelihood of high blood pressure.34 Other health effects related to the abuse of alcohol 
include cardiovascular problems, cancer, liver diseases, gastrointestinal issues, and social 
dysfunction.35 Alcohol can also directly affect the nervous system causing conditions such as 
neuropathy, dementia, psychosis, Wernicke’s encephalopathy (which presents as paralyzed eye 
movements, difficulty walking, and confusion), stroke, and death.36 Although the health effects 
of alcohol and blood pressure have been studied abundantly, most of this research has centered 
on alcohol as an exposure through consumption by adults. Another exposure pathway in which 
alcohol may be affecting the prevalence of childhood hypertension is through prenatal exposure.  
During pregnancy, alcohol that is consumed by the mother passes through the placenta 
and transfers to the baby via the umbilical cord.37 Within the U.S., it is estimated that 
approximately 12% of pregnant mothers drink alcohol; despite the recommendations of experts, 
including the Surgeon General, who report that there is no level of alcohol consumed during 
pregnancy that is considered safe for the mother and the developing fetus.38 The same prenatal 
transference of alcohol that leads to FAS and FASDs might also be contributing to an increased 
likelihood of hypertension in youth. The purpose of this study is to examine the relationship 
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between prenatal exposure to alcohol, manifested through FAS, and hypertension in children, 
adolescents, and young adults. 
Literature Review: 
Although there has been much study on FASDs, FASD research is still lacking compared 
with the abundance of research on other developmental disorders, such as autism and ADHD, 
which have consistently been improving in overall awareness.40,41 In particular, there is virtually 
no research that has been conducted which specifically connects Fetal Alcohol Syndrome (FAS) 
with blood pressure outcomes. 
Cardiovascular Defects 
One of the most damaging outcomes of FASD is the impact that maternal alcohol use has 
on the developing fetal cardiovascular system.  Research has shown that prenatal alcohol 
exposure, manifested through FASDs, significantly increases the likelihood of congenital and 
conotruncal heart defects.42,43 Congenital heart defects frequently lead to cardiovascular 
abnormalities such as holes in the heart and narrowed vales; conditions which often present 
clinically as hypertension.44, 69 Conotruncal heart defects, which often result in right ventricular 
hypertrophy and pulmonary hypertension, also have been shown to be more likely to present in 
offspring who’s mothers consumed alcohol during the periconceptional phase of pregnancy.68 
Additionally, FAS has been identified in individuals with midaortic syndrome; a rare condition 
that narrows the abdominal aorta and presents as untreatable hypertension.67 
Recently it has been found that reversed blood flow within the developing heart, 
influenced by prenatal alcohol exposure, may be the primary catalyst for defective heart 
formation during the critical stages of embryonic development.45 Specifically, alcohol-exposed 
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fetuses have an increased risk of developing defects such as ventricular septal defects (VSDs), 
Patent Ductus Arteriosus (PDA), and narrowed valves.72,73 Heart defects such as these often 
symptomatically present as high blood pressure in the affected individual.46,47,48 
Reduction in Nephrons 
Research has also shown that prenatal alcohol exposure results in an overall reduction of 
nephrons in the developing fetus.49 Nephrons are the primary functional unit of the kidneys and 
are critical in the regulation of water and sodium through blood filtration.50 A reduction in 
nephrons results in a weakening of the cardiovascular system and impaired renal function.77 
Specifically, reduced nephrons have been shown to correlate with an overall increase in mean 
arterial pressure (MAP).51 Impaired cardiovascular and renal function have also been proven, 
independently, to correlate with non-normative blood pressure readings and an increased 
likelihood of hypertension.52,53 There are no studies, however, examining the relationship 
between FAS and hypertension status within this context. 
Purpose of Study 
This study is aimed at bringing to light the potentiality of prenatal alcohol exposure as a 
determinant of high blood pressure in youth. The study samples contain data from participants 
ages 3 to 17 (n=342) and includes 165 cases diagnosed with either fetal alcohol syndrome (FAS) 
or partial fetal alcohol syndrome (pFAS) compared to 177 controls without a diagnosis of FAS 
or pFAS. The findings will shed light on the potential outcomes of drinking alcohol while 
pregnant and provide the basis for a more comprehensive health screening process when 
evaluating FAS-affected patients.54 
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Methods: 
Design 
A case-control design was used for the purposes of this research study. Data comes two 
distinct sources. Cases (n=165) were taken from a clinical database abstracted from the Fetal 
Alcohol Syndrome and Drug Exposure Center at the Marcus Autism Center in Atlanta, Georgia. 
Information on cases was collected through patient medical records, cognitive and intellectual-
assessment evaluations, and demographic/family-history surveys. The database houses patient 
data during initial and follow-up FAS clinic sessions and includes records spanning from 2000 
through 2006. Controls (n=177) were taken from the National Health and Nutrition Examination 
Survey (NHANES) from the 2005-2006 dataset. NHANES is a nationally-representative survey 
administered by the Centers for Disease Control and Prevention (CDC) designed to assess the 
health and nutrition of the U.S. population. NHANES houses both interviews and physical 
examinations and contains dietary information, demographics, medical conditions, and 
laboratory tests. 
Participants 
The sample includes participants’ ages 3 to 17 (mean age = 10.48, SD = 4.21) who 
provided consent for their information to be used in further research. Participants under the age 
of 3 were eliminated from the sample in order to remain consistent with the National Heart, 
Lung, and Blood Institute’s blood pressure measurement conventions for children and young 
adults; which does not indicate standard blood pressure thresholds for those under 3 years of 
age.58 The sex of the sample participants was relatively evenly distributed with 53.5% of the 
sample being male (n=183) and 46.5% female (n=159). There were greater number of non-
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Hispanic Blacks (NHBs) in the sample (n=143; 41.8%) than other race/ethnicities; this was in 
congruence with the race/ethnicity distribution of patients regularly seen at the FAS clinic. Non-
Hispanic Whites within the sample totaled to 124 (36.3%), Hispanics totaled to 53 (15.5%), and 
all others totaled to 22 (6.4%). FAS-status was the primary independent variable of interest and 
was treated as an indicative determinant of hypertension status.   
Measures  
FAS-status is assessed by diagnoses taken from the FAS Team Interdisciplinary 
Evaluation Form; a form summarizing the diagnoses and recommendations for the patient from a 
multidisciplinary panel of experts. The presence or absence of FAS in each patient within the 
sample is categorized based upon confirmed vs. non-confirmed diagnoses. Diagnosis of fully-
developed FAS includes 4 diagnostic criteria: facial dysmorphia, growth problems, central 
nervous system abnormalities, and confirmed maternal alcohol exposure.56 Partial fetal alcohol 
syndrome, or pFAS, is diagnosed when there is confirmation of both maternal alcohol exposure 
and facial abnormalities in addition to either growth retardation, central nervous system 
abnormalities, or delayed cognitive and behavioral development without an otherwise specified 
cause.57 Because of the similarities of the alcohol exposure mechanisms and diagnostic criteria of 
FAS and pFAS, both were categorized with a positive FAS-status. 
The blood pressure of the cases was measured through systolic and diastolic readings 
taken from the arm by a licensed nurse practitioner during FAS evaluation visits to the Marcus 
Autism Center. Hypertension status was assessed by categorizing blood pressure readings into a 
variable that labels participants as having either a non-risk or at-risk blood pressure level. At-risk 
levels include those whose blood pressure reading is in the range of hypertension; a condition 
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which is considered to be “at-risk” for atherosclerosis, heart disease, stroke, congestive heart 
failure, blindness, and kidney disease.59 Non-risk levels are coded as blood pressure readings 
below the systolic/diastolic threshold for hypertension; non-risk levels also include blood 
pressure levels in the range of prehypertension. In patients between the ages of 3 and 17, at-risk 
blood pressure thresholds are assessed by conventions set within the National High Blood 
Pressure Committee's Fourth Report; which sets hypertension thresholds based upon sex, height, 
and age (in years) cateogiricals.55 
To address potential confounding, race and ethnicity are factored into the analysis and 
aggregated into one variable which is categorized as either Hispanic, non-Hispanic White, non-
Hispanic Black, or other; sex is categorized into either male or female. Case data relating to race, 
ethnicity, and sex are abstracted from the FAS Team Interdisciplinary Report, which includes 
data on demographic factors ascertained through guardian/caregiver self-report from Marcus 
Autism Center and the Fetal Alcohol Syndrome and Drug Exposure Center medical records. 
Control demographic data was taken directly from the 2005-2006 NHANES. Age is measured in 
whole and half-years and calculated by subtracting the birthdate from the exam date and 
truncating the resulting value. Medications in use by the patient, obtained through patient 
medical records, guardian/caregiver report, and NHANES, are aggregated into the analysis in 
order to avoid potential confounding that may result from medicinally-elevated blood pressure 
readings. A bivariate variable was created that categorized each participant as either on 
medication or off medication at the time of examination. Obesity has been shown to be directly 
correlated with hypertension and, thus, was also factored into the analysis as a potential 
confounder.60 Obesity was measured as having a body mass index (BMI) of 30 or greater; 
calculated as weight (in kg) divided by height2 (in cm).61 
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Analytic Plan 
Chi-square analyses were used to examine the extent to which FAS status, sex, 
race/ethnicity, medication use, and obesity status each relate to hypertension status. A logistic 
regression was performed to analyze the association between the diagnosis of FAS and 
hypertension status. Categorical variables relating to FAS-status, race/ethnicity, sex, obesity, and 
medication use were included into the regression as possible predictors of hypertension status; 
hypertension status was the primary outcome measure and was coded as 0 = hypertensive, 1 = 
not hypertensive. 
Results: 
The total proportion of youth classified as hypertensive (12%) was over three times 
greater than the national average of hypertension in youth (3.6%).62 Hypertension prevalence 
within the FAS-positive cases sampled from the FAS clinic was much higher (19.4%) than the 
prevalence of hypertension seen in controls sampled from the NHANES (5.1%). Other 
demographic characteristics are shown in Table 1. 
Table 1.  
Demographic Characteristics of Sample Populations.  
Variable FAS Clinic Sample 
(cases) 
NHANES Sample 
(controls) 
Total 
Sample size 165 177 342 
Mean age (std dev.) 7.15 (3.58) 13.13 (2.70) 10.25 (4.34) 
Sex    
Male (%) 57.6 49.7 53.5 
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Female (%) 42.4 50.3 46.5 
Race/Ethnicity1    
NHC (%) 44.8 28.2 36.3 
NHAA (%) 49.7 34.5 41.8 
Hispanic (%) .6 29.4 15.5 
Other (%) 
Medication Use 
4.8 7.9 6.4 
Yes (%) 66.1 26.0 45.3 
No (%) 33.9 74.0 54.7 
Obesity    
Yes  (%) 2.4 7.9 5.3 
No  (%) 97.6 92.1 94.7 
1. NHAA is non-Hispanic African American, NHC is non-Hispanic Caucasian. 
 
A chi-square test of independence was performed to examine the relationship between 
each demographic variable of interest and hypertension status. Results indicated in Table 2.  
 
Table 2 
Chi-square test of independence and odds ratio for each variable of interest predicting 
hypertension status. 
Variable %(n)1 x2 df OR p 
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FAS Status  16.57 1 4.49 >.001 
    Yes 19.4(165)     
     No 5.1(177)     
Sex  .13 1 1.13 .723 
    Male 12.6(183)     
    Female 11.3(159)     
Race/Ethnicity2      
    Non-Hispanic Caucasian 12.1(124) .00 1 1.02 .963 
    Non-Hispanic African American 11.9(143) .00 1 .98 .961 
    Hispanic 7.5(53) 1.17 1 .56 .279 
    Other 22.7(22) 2.57 1 2.32 .109 
Medication Use  9.92 1 2.95 .002 
    Yes 18.1(155)     
     No 7.0(187)     
Obesity Status  .39 1 1.50 .534 
    Yes 16.7(18)     
     No 11.8(323)     
1Percentage represents the proportion of participants within each categorical that presented 
with hypertensive blood pressure readings; n represents the total number of participants in each 
sub-categorical. 
2Difference between groups was tested by Pearson chi-square statistic. Each Race/ethnicity 
categorical (non-Hispanic Caucasian, non-Hispanic African American, Hispanic, and other) 
was compared separately against all other races/ethnicities. 
 
The relationships between FAS status and hypertension status (OR=4.49, p<.001) as well 
as medication use and hypertension status (OR= 2.95, p=.002) proved to be statistically 
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significant. Those diagnosed with FAS had a larger proportion of respondents who were using 
medication (66.06%, n=109) than those without a diagnosis of FAS (25.99%, n=46). Additional 
chi-square analyses found that participants with FAS were also far more likely (OR=5.54, 
p<.001) to be on medication than those without a diagnosis of FAS. The most common types of 
medications that the FAS-diagnosed youth were using were either stimulants and/or selective 
serotonin reuptake inhibitors (SSRIs). Expectedly, most of participants with a positive FAS 
status were also underweight (79.39%); a function of the diagnostic criteria for FAS which 
includes reduced anthropometric growth. Initial demographic analyses also showed that 23% of 
the FAS clinic sample were reported as having asthma; a proportion much higher than the 
national average of asthma which is estimated to be between 7 to 10 percent.80 In fact, 25.7% of 
the FAS clinic sample was on some type of allergy or asthma medication at the time of 
examination. 
In order to assess the potential for an unmediated relationship between FAS and 
hypertension, a logistic regression was performed that controlled for sex, race/ethnicity, 
medication use, and obesity status. Results indicated in Table 2.  
Table 3  
Logistic regression model of predictors of hypertension status in children, adolescents, and 
young adults ages 3-17. 
Predictor β SE β Wald's x2 df p OR C.I.(p<.05) 
Constant -.86 .97 .78 1 .378 N/A N/A N/A 
FAS Status 1.65 .52 10.21 1 .001 5.18 1.89 14.23 
Sex (male is reference)  .02 .35 .00 1 .967 1.02 .51 2.03 
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Race/Ethnicity 
White (reference)         
Non-Hispanic African American 1.26 .64 3.86 1 .049 3.52 1.00 12.37 
Hispanic 1.19 .64 3.52 1 .061 3.29 .95 11.44 
Other .49 .84 .34 1 .562 1.63 .31 8.46 
Medication Use .64 .39 2.66 1 .103 1.90 .88 4.11 
Obesity Status .98 .73 1.82 1 .177 2.66 .64 11.00 
N: The dependent variable used in the regression was hypertension status (yes=0, no=1). 
Predictors include: FAS status: measured as confirmed diagnosis of FAS or pFAS (yes=0, 
no=1), sex, medication use (yes=0, no=1), obesity status (yes=0, no=1), and race/ethnicity. The 
sex categorical compared females to males through the regression (female=0, male=1). The 
non-Hispanic Caucasian race/ethnicity categorical was used as the reference value during the 
regression in order to compare outcomes for participants with the races/ethnicities listed (Non-
Hispanic African American, Hispanic, Other) against participants classified as non-Hispanic 
Caucasian.  
 
The results from Table 3 indicated a significant association between FAS status and 
hypertensions status after controlling for potential confounders. FAS status significantly 
predicted hypertension status (β = 1.646, OR = 5.184, p< .001) after accounting for sex, 
race/ethnicity, medication use, and obesity status. Similar to findings presented in previous 
studies, race/ethnicity showed a direct relationship with hypertension status.63 Compared to those 
having a race/ethnicity classified as non-Hispanic Caucasian, having a minority race/ethnicity 
classification, which included non-Hispanic African American (β =1.259, OR = 3.523, p = .049) 
and Hispanic (β = 1.192, OR = 3.294, p = .061), seemed to increase the likelihood of having 
hypertensive blood pressure readings. Though significant in its bivariate relationship with 
hypertension status, medication use was not significant in the multivariate regression. 
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Discussion: 
FAS and hypertension are conditions that greatly burden healthy functioning, 
development, and life outcomes in children and adults. FAS and pFAS-affected youth face an 
increased risk for cardiovascular defects, reduced nephron profusion, and high stress levels; all 
potential determinants of high blood pressure. Combined, one might expect that these factors 
elevate the likelihood of developing high blood pressure in individuals with FAS or pFAS and 
potentially those on the less severe end of the FASD spectrum.  
FAS and Hypertension 
Results from this study indicated an unmediated relationship between FAS status and 
hypertension status in children, adolescents, and young adults. The biological mechanism 
catalyzing this relationship most likely corresponds with the placental transference of alcohol 
during gestation. Generally, hypertension occurrence in children and adolescents is relatively 
rare compared with rates seen in older age groups.78 In the FAS-affected participants of the study 
sample, the prevalence of high blood pressure greatly exceeds the national average in youth.62 
The evidence presented in this report, in addition to previous studies examining the impact age 
has on the risk of hypertension, suggests that rates of hypertension in FAS-affected individuals 
may be exponentially higher in adulthood.  
Race/Ethnicity 
As supported by previous literature, the regression performed showed that race/ethnicity 
proved important in predicting hypertension status. Ethnic minorities within the sample yielded a 
much higher likelihood of having hypertension than those classified as non-Hispanic Caucasian. 
Non-Hispanic African Americans in particular seemed disproportionately burdened with 
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hypertensive blood pressure readings. Previous research has shown that non-Hispanic African 
Americans not only face greater severity and mortality in regards to high blood pressure, but are 
also more likely than others to develop hypertension in childhood.63,70 Because the age range of 
the sample is limited to children and young adults, the prevalence of hypertension might be 
relatively elevated in non-Hispanic African Americans due to an increased tendency to develop 
high blood pressure earlier in life. To better examine the extent to which race/ethnicity impacts 
hypertension status in FAS and alcohol-affected individuals, a longitudinal study following a 
more ethnically-diverse sample into adulthood is needed. 
Limitations and Implications 
There are several limitations that arose during the course of this study. As a product of 
the structural design of the FAS clinic survey and database, income and socioeconomic status 
(SES) were not available or factored into the analysis. The inclusion of SES into the study would 
have been beneficial in assessing the extent to which environmental factors play a role in the 
relationship between FAS and hypertension. FAS-affected youth are often part of households 
with low socioeconomic status and poor social support.64 Research also shows that low SES and 
being below the poverty line are significantly associated with an increased risk for high blood 
pressure.71 This phenomenon could be partly due to the challenges individuals with low SES face 
in regards to access to healthcare, knowledge about the prevention and control of hypertension, 
and nutrition.79 Through this context, SES could potentially have a mediating affect in the 
relationship between FAS and hypertension status. 
The second major limitation of this study relates to the controls sampled from NHANES. 
Because NHANES does not contain a variable that specifically contains information on FAS 
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diagnosis, a lack of diagnosis was assumed due to the relative rarity of confirmed cases of FAS 
and pFAS present in the general population. Although unlikely, the differential misclassification 
of exposure of FAS-affected individuals as controls could potentially diminish the statistical 
power of the relationship between FAS and hypertension and underestimate an otherwise larger 
predictive value. Establishing an alternative source for controls that incorporates comprehensive 
diagnostic information, possibly from other clinics or hospitals, would help eliminate this 
limitation and improve predictive accuracy in future studies relating to FAS and hypertension. 
This study was also limited in that, within the FAS clinic sample of cases, blood pressure 
was only measured at one point in time. To make the hypertension categorization of the controls 
equivalent to the cases, blood pressure readings from the NHANES were also limited to the first 
measurement. The most precise diagnoses of hypertension involve approximately three blood 
pressure readings that are taken on distinctly different days. This is done to reduce the likelihood 
of white-coat hypertension, and other environmental factors, that may contribute to spiked blood 
pressure readings during one or more of the measurements.65 Although single measurements are 
not ideal for assessment, initial measurements should not vastly differ statistically from results 
indicated from multiple readings. In addition, the sample size is large enough to significantly 
decrease the potential impact of anomalous blood pressure measurements during hypertension 
categorization and analysis. As such, blood pressure evaluation and hypertension categorization 
would be more precise if multiple readings were included, but, for the purposes of this study, 
initial readings prove sufficient. 
One major implication of this study is that the findings could be used to develop a more 
comprehensive health screening process during clinical FAS evaluation. Implementing interval-
based sphygmomanometer readings and, where necessary, non-invasive echocardiography into 
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FAS clinic evaluations could better identify hypertensive patients. This could potentially lead to 
earlier identification of at-risk blood pressure levels and reduce the overall impact of 
hypertension in many FAS-affected individuals.   
Another implication of this report is that the results shed more light on the diversity and 
complexity of health burdens faced by individuals diagnosed with FASDs. Identifying 
hypertension as an additional source of morbidity for youth with FAS could elevate the research 
interest and overall awareness surrounding the devastating effects of prenatal alcohol exposure. 
This could potentially lead to more comprehensive and effective maternal alcohol use prevention 
efforts that incorporate the interaction between prenatal alcohol exposure and hypertension. 
Conclusion 
The major findings of this study suggest a significant relationship between FAS and 
hypertension in youth. Race/ethnicity also proved important in predicting hypertensive blood 
pressure readings independent of FAS diagnosis. The most obvious biological mechanism 
catalyzing the relationship between FAS and hypertension is prenatal alcohol exposure. Because 
prenatal alcohol exposure is the primary definitional and diagnostic factor of FAS, associative 
connectivity may exist independently between prenatal alcohol exposure and blood pressure at 
various levels of severity along an alcohol-exposure, dose-response spectrum. Further research is 
needed to isolate and measure the effect that prenatal alcohol exposure has on blood pressure 
independently of FAS diagnosis whilst assessing the extent to which the risk for hypertension in 
alcohol-affected individuals increases with age and through the life course. Factoring in SES and 
a more diverse race/ethnicity categorical would also be beneficial in future studies to further 
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reduce mediation and improve the statistical power of the relationship between prenatal alcohol 
exposure, presenting as FAS, and hypertension. 
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